Surgical Oncology | Duke Department of Surgery - duke university breast cancer treatment


duke university breast cancer treatment - Breast Cancer Cells Starve For Cystine | Duke Today

To make an appointment, please call 888.275.3853.. For more information on breast cancer care at Duke Health, visit Breast Cancer Treatment Options: Expert Guidance for Your Breast Cancer Care.. To find a doctor, visit Find A Specialist. Duke Cancer Institute constellates the world-class resources of Duke University, Duke Health and the Duke Comprehensive Cancer Center into a collaborative powerhouse. We are poised to drive a paradigm shift in the way long-established cancer centers and institutes have been waging this war. Learn More ×.

You don’t have to travel far to receive the latest advances in cancer care. Duke cancer centers in Durham, Raleigh, and Cary offer you access to cancer doctors, treatment advances, and clinical trials only available at the best cancer hospitals in the U.S. The Section of Breast Surgery is a world-class team of surgeons, staff, and researchers dedicated to the care and treatment of patients with breast cancer and breast disease. We are committed to providing excellent and compassionate care for over 1,200 patients a year, as well as increasing effectiveness and improving long-term quality of life for our patients with breast.

In 1972, the Duke Comprehensive Cancer Center, now known as the Duke Cancer Institute (DCI), was established and designated by NCI as one of the first comprehensive cancer centers. The DCI serves as the focus for all of Duke University’s activities in cancer. Cancer ratings are based on analysis of various data categories: patient outcomes in the medical and surgical treatment of cancer, volume of high-risk patients, patient experience, nurse staffing.

Nov 21, 2016 · In a new study, Duke University scientists report that cells from a vicious and treatment-resistant form of breast cancer, called triple negative breast cancer (TNBC), die off rapidly when deprived of a key nutrient called cystine. DURHAM, N.C. -- Active surveillance could be a viable alternative to surgery and radiation for select patients with ductal carcinoma in situ, or DCIS, according to a mathematical model developed by researchers at Duke University. The watch-and-wait approach shows particular relevance to older women and those with additional serious health problems.

Preoperative Single-Fraction Radiotherapy in Early Stage Breast Cancer Duke Principal Investigator: Dr. Janet Horton. Study of Preoperative Boost Radiotherapy Duke Principal Investigator: Dr. Janet Horton. Standard or Comprehensive Radiation Therapy in Treating Patients With Early-Stage Breast Cancer Previously Treated With Chemotherapy and Surgery. Duke's nationally recognized cancer treatment programs combine cutting-edge research with compassionate care to treat more than 7,000 new cancer patients each year. This volume gives our team the extensive experience that yields better results. Learn More.